Many healthcare and life sciences companies genuinely want to be patient-centric some already believe they are. But there's a blind spot built into how most strategy gets made: patients get seen as data points, protocols, and market metrics. Designing strategy from inside a boardroom misses the raw, daily reality of actually living with a diagnosis. I know this gap firsthand. I spent four decades as a patient watching decisions get made in rooms I wasn't in. Decisions about m

During my five years in a clinical trial, adherence wasn't an abstract healthcare term, it was four-hour drives to and from my study site, over and over. It was being pushed into cardiac rehab before my body was actually ready, and spending early sessions battling blood pressure drops instead of building strength. "Non-adherence" is a clinical word for something much more human: people falling through the cracks of their own care. Missed doses. Skipped follow-ups. Lifestyle c

I didn’t. Not for decades. I walked around believing my heart was the one part of me that was still “fine.” I trusted that silence meant safety. I trusted that no news meant good news. But here’s the truth I learned the hard way. Sometimes the heart is the last one to speak up and by the time it does, the damage has already been building for years. For me, the story didn’t start with a cardiologist. It started almost forty years earlier, in my lungs. I was diagnosed with idio

Everyone loves the miracle story. Hospice. No options left. Then a clinical trial. Then a second chance. For me, that second chance came through the early feasibility study of the EVOQUE transcatheter tricuspid valve replacement. I later continued follow-up as part of the TRISCEND II research studying this therapy for people living with severe tricuspid regurgitation, But what people don’t talk about very often is what happens after the miracle. When the swelling finally s

There’s a moment in healthcare that quietly shapes everything that comes after. I’ve lived it. It isn’t the test result, the gradient numbers, or even the final diagnosis. It’s the first contact. The first look. The first tone of voice. For me, that moment of safety didn't happen in a consultation room, it happened in a hallway during a 6-minute walk test. The Voice I Already Knew I remember my initial visit with the clinical trial doctors. It was during the height of COVID,